FOR IMMEDIATE RELEASE Theraclone Sciences’ I-‐STAR™ Technology Chosen by Wellcome Trust to Identify Therapeutic Antibodies Against Ebol

First Page		Document Content
Date: 2015-04-30 08:07:06 Ebola Ebola virus disease Mononegavirales Zoonoses Biologic Antibody Virus Cambridge Antibody Technology Symphogen Biology Medicine Immune system		FOR IMMEDIATE RELEASE Theraclone Sciences’ I-‐STAR™ Technology Chosen by Wellcome Trust to Identify Therapeutic Antibodies Against Ebol Add to Reading List Source URL: www.theraclone-sciences.com Download Document from Source Website File Size: 66,46 KB Share Document on Facebook

	Nominations are invited from laboratories under the Department of Health Research (DHR) – Virus Research and Diagnostic Laboratory (VRDL) Network , Govt. Hospitals and Govt. Medical Colleges of Bihar, Jharkhand and Wes DocID: 1vsaf - View Document
	Lymphocytic Choriomeningitis Virus (LCMV) Introduction The Alabama Department of Public Health (ADPH) and the Alabama Department of Agriculture and Industries (ADAI) are working with the Centers for Disease Control and P DocID: 1vqhB - View Document
	BIOLOGICAL SCIENCES Respiratory Virus Study Points to Vaccine Target Scientific Achievement DocID: 1vpI1 - View Document
	UTILIZING WILD CAPSICUM ANNUUM (CHILE PEPPER) FOR BREEDING BEET CURLY TOP VIRUS RESISTANCE IN CULTIVATED HOT PEPPERS Jimenez R.C.1, Chen L.F.2, Gilbertson R.L.2, Hill T.H. 1, Van Deynze A.E.1 1 Plant Sciences Department, DocID: 1vpmi - View Document
	Death of a Salesforce Whatever happened to anti-virus? David Harley, ESET Senior Research Fellow, ESET North America Larry Bridwell, Independent Researcher DocID: 1vm1M - View Document